We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SVT:LSESevern Trent Plc Analysis

Data as of 2026-06-19 - not real-time

£2,842.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Severn Trent is trading at £2,842, roughly 11.5% below the DCF‑derived fair value of £3,914, suggesting a material upside potential. The stock’s PE ratio of 23.1 sits above the industry average of 20.6, but the forward PE of 11.7 indicates earnings are expected to accelerate, supported by a robust 15.3% revenue growth year‑over‑year. Technicals show a neutral trend with the 20‑day SMA (2950.5) just above price, a low RSI of 36 hinting at near‑term oversold conditions, and a bearish MACD divergence, while volume is decreasing, adding a cautionary note.
The company reported a significant £1.9 bn capital investment and highlighted “exceptional growth” in its latest earnings call, reinforcing its long‑term earnings narrative. However, the balance sheet is heavily levered (debt‑to‑equity ~597) and free cash flow remains negative, and the firm does not currently pay a dividend, raising concerns about cash generation sustainability. Overall, the combination of undervaluation, growth prospects, low beta, and regulated utility stability makes SVT an attractive candidate for investors with a medium‑to‑long‑term horizon, while short‑term traders should monitor technical support at £2,836 and volume trends.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near technical support at £2,836
  • RSI indicating oversold conditions
  • Potential upside of ~11% based on DCF

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 15% revenue growth and forward PE compression
  • Capital investment driving future earnings
  • Undervalued relative to fair value

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Regulated water utility with stable cash flows
  • Long‑term growth from infrastructure spend
  • Low beta and defensive sector positioning

Key Metrics & Analysis

Financial Health

Revenue Growth15.30%
Profit Margin13.10%
P/E Ratio23.1
ROE20.54%
ROA3.23%
Debt/Equity596.63
P/B Ratio4.6
Op. Cash Flow£1.3B
Free Cash Flow£-1170000000
Industry P/E20.6

Technical Analysis

TrendNeutral
RSI36.1
Support£2,836.00
Resistance£3,176.00
MA 20£2,950.50
MA 50£3,060.04
MA 200£2,899.73
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair Value£3,914.39
Target Price£3,169.31
Upside/Downside11.52%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.02
Volatility31.69%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.